Predictors of Changes in Alcohol Craving Levels during a Virtual Reality Cue Exposure Treatment among Patients with Alcohol Use Disorder

Autor: Lidia Teixidor, Antoni Gual, Jolanda Fernández-Ruiz, Maribel Fernández, Alexandra Ghiţă, Miquel Monras, José Gutiérrez-Maldonado, Lidia Ugas-Ballester, Natàlia Figueras-Puigderrajols, Lluisa Ortega, Olga Hernández-Serrano, Silvia Mondon, Roger Montserrat, Bruno Porras-Garcia, Marta Ferrer-García
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Journal of Clinical Medicine; Volume 9; Issue 9; Pages: 3018
Journal of Clinical Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, 2020, vol. 9, núm. 9, p. 3018
Articles publicats (EUSES)
DUGiDocs – Universitat de Girona
instname
Journal of Clinical Medicine, Vol 9, Iss 3018, p 3018 (2020)
ISSN: 2077-0383
DOI: 10.3390/jcm9093018
Popis: Background/Objective: Determining the predictive variables associated with levels of alcohol craving can ease the identification of patients who can benefit from treatments. This study aimed to describe changes (improvement or no change/deterioration) in alcohol craving levels and explore the predictors of these changes from admission to discharge in outpatients with alcohol use disorder (AUD) undergoing treatment-as-usual (TAU), or treatment-as-usual supplemented with virtual reality cue-exposure therapy (TAU + VR-CET). Method: A prospective cohort study was conducted amongst 42 outpatients with AUD (n = 15 TAU + VR-CET and n = 27 TAU) from a clinical setting. Changes in the levels of alcohol craving between admission and discharge were assessed with the Multidimensional Alcohol Craving Scale. Sociodemographic characteristics (age, gender, education, and socioeconomic and civil status), cognitive-affective behavioral patterns (AUD severity, abstinence duration, psychiatric comorbidity, state anxiety, attentional bias, and substance use), and type of treatment (TAU + VR-CET and only TAU) were also evaluated. Results: The TAU + VR-CET group showed greater changes of improvement in the levels of alcohol craving than the TAU group (χ2 = 10.996; p = 0.001). Intragroup changes in alcohol craving from pre to post-treatment were significant in the TAU + VR-CET group (χ2 = 13.818; p = 0.003) but not within the TAU group (χ2 = 2.349; p = 0.503). The odds of an improvement in any of the craving levels between pre- and post-test was 18.18 (1/0.055) times higher in the TAU + VR-CET group with respect to the TAU group. The use of illicit drugs in the month prior to the test increased the odds of having a positive change by 18.18 (1/0.055) with respect to not having consumed. Conclusions: Including VR-CET in TAU programs may provide benefits in the treatment of AUDs mainly among patients with intense alcohol craving and individuals having used illicit substances prior to treatment This research was funded by the Spanish Ministry of Health, Social Services and Equality, Delegation of the Government for the National Plan on Drugs (FEDER/EU/Project 2016I078: ALCO-VR: Virtual reality-based protocol for the treatment of patients diagnosed with severe alcohol use disorder). The study also received support from AGAUR, Generalitat de Catalunya, 2017SGR1693
Databáze: OpenAIRE